Gmail Calendar Documents Reader Web more »
Recently Visited Groups | Help | Sign in
Google Groups Home
misc.invest
About this group
Subscribe to this group
This is a Usenet group - learn more
What happened to Royce Labs (RLAB)
Options
There are currently too many topics in this group that display first. To make this topic appear first, remove this option from another topic.
There was an error processing your request. Please try again.
flag
   3 messages - Collapse all  -  Translate all to Translated (View all originals)
The group you are posting to is a Usenet group. Messages posted to this group will make your email address visible to anyone on the Internet.
Your reply message has not been sent.
Your post was successful
 
From:
To:
Cc:
Followup To:
Add Cc | Add Followup-to | Edit Subject
Subject:
Validation:
For verification purposes please type the characters you see in the picture below or the numbers you hear by clicking the accessibility icon. Listen and type the numbers you hear
 
Ed Dougherty  
View profile  
 More options Apr 28 1992, 1:21 am
Newsgroups: misc.invest
From: e...@gvlf2.gvl.unisys.com (Ed Dougherty)
Date: 27 Apr 92 15:21:52 GMT
Local: Tues, Apr 28 1992 1:21 am
Subject: What happened to Royce Labs (RLAB)
Reply to author | Forward | Print | Individual message | Show original | Report this message | Find messages by this author
A while back there was some discussion about RLAB (over priced);
I owned it at the time and sold it after hearing bad rumors.

Since then it shot up for a while but last week it lost 3+ to
close in the $4 range.  Does anyone know what happend to it,
did the bad new finally break?

Ed Doc


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
Daniel Maturo  
View profile  
 More options Apr 28 1992, 4:18 am
Newsgroups: misc.invest
From: djm@hydrus (Daniel Maturo)
Date: Mon, 27 Apr 92 18:18:00 GMT
Subject: Re: What happened to Royce Labs (RLAB)
Reply to author | Forward | Print | Individual message | Show original | Report this message | Find messages by this author
In article <1992Apr27.152152.2...@gvl.unisys.com> e...@gvlf2.gvl.unisys.com  

(Ed Dougherty) writes:
> A while back there was some discussion about RLAB (over priced);
> I owned it at the time and sold it after hearing bad rumors.

> Since then it shot up for a while but last week it lost 3+ to
> close in the $4 range.  Does anyone know what happend to it,
> did the bad new finally break?

> Ed Doc

On 4/22, Royce Labs received a 'NOT APPROVAL' letter from the FDA on it's  
Piroxicam drug (a generic equivalent of Feldene.)  This is because of a  
number of discrepencies and inconsistencies associated with manufacturing  
and testing records for the Piroxicam application.  The company has  
received substantial orders for Piroxicam and has manufactured sufficient  
quantity to fill these orders, but cannot ship due to the FDA  
determination.  This could cost the company $1,500,000 in the current  
period.

Dan Maturo
d...@fnbc.com


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
Ed Zhong  
View profile  
 More options Apr 28 1992, 4:49 am
Newsgroups: misc.invest
From: e...@introl.introl.com (Ed Zhong)
Date: 27 Apr 92 18:49:04 GMT
Local: Tues, Apr 28 1992 4:49 am
Subject: Re: What happened to Royce Labs (RLAB)
Reply to author | Forward | Print | Individual message | Show original | Report this message | Find messages by this author

In article <1992Apr27.152152.2...@gvl.unisys.com> e...@gvlf2.gvl.unisys.com (Ed Dougherty) writes:
>A while back there was some discussion about RLAB (over priced);
>I owned it at the time and sold it after hearing bad rumors.

>Since then it shot up for a while but last week it lost 3+ to
>close in the $4 range.  Does anyone know what happend to it,
>did the bad new finally break?

>Ed Doc

FDA failed to approve on RLAB's Piroxicam, the generic version of
Pfizer's Feldene. Currently Feldene has a $400 mil/year market.

If Piroxicam passed FDA's examination, RLAB could easily skyrocket
to $12 range. People gambled on it... too bad, they were not lucky
enough.

CRAY is another gambling item. If CRAY find a customer tomorrow, the
stock will be as high as $10.

P.S. RLAB can apply for FDA's approval on Piroxicam again.

--Ed
--
-------------                   -----------------
||      Ed Zhong                ||      I make my money work for me.
||      e...@introl.com         ||      I work for making my money work for me.


    Reply to author    Forward  
You must Sign in before you can post messages.
To post a message you must first join this group.
Please update your nickname on the subscription settings page before posting.
You do not have the permission required to post.
End of messages
« Back to Discussions « Newer topic     Older topic »

Create a group - Google Groups - Google Home - Terms of Service - Privacy Policy
©2009 Google